肾系膜细胞是血管周围细胞，位于肾小球毛细血管袢之间的中央部位。系膜细胞有多种功能，包括合成和组装的系膜基质，内吞作用和处理血浆大分子，通过系膜细胞收缩或血管活性激素的释放[1]调控肾小球血流动力学。系膜细胞也能合成，聚集和控制肾小球系膜基质成分的变化。在多种肾小球疾病中，如IgA肾病、膜增生性肾小球肾炎、狼疮性肾炎、肾小球硬化症、糖尿病肾病等，均能检测到肾小球系膜基质的生产过剩[2，3]。这些关键的作用表明肾系膜细胞是研究生理和病理环境下系膜损伤和肾小球功能的理想模型。
Sciencell研究实验室的人肾系膜细胞是从人的肾脏组织中分离得到的，纯化后冻存，冰冻运输。每管细胞密度超过5×10^5/ml。该细胞可通过纤连蛋白、Thy-1和平滑肌肌动蛋白特异性抗体的免疫荧光进行鉴定。本细胞经检测不含HIV-1、HBV、HCV、支原体、细菌、酵母菌和真菌。如采用ScienCell 实验室特制的培养基，可保证此细胞15倍增殖。
推荐培养基：肾系膜细胞培养基 (MCM, Cat. #4201)
|
货号
|
4200
|
|
产地
|
美国
|
|
缩写
|
HRMC
|
|
规格
|
5 x 10^5/1ml
|
|
用途
|
科研
|
|
储存
|
液氮
|
|
运输
|
干冰
|
|
关键字
|
人肾系膜细胞 HRMC 人肾系膜细胞 HRMC 人肾系膜细胞 HRMC 人肾系膜细胞 HRMC 人肾系膜细胞 HRMC 人肾系膜细胞 HRMC
|
公司简介
|
合肥星肽生物科技有限公司作为专业的ScienCell中国代理商，专业经营实验室科研用原代细胞、原代细胞专用培养基、原代细胞无血清培养基、干细胞、干细胞培养基、干细胞无血清培养基的研究和开发。合肥星肽生物科技有限公司始终致力于为客户提供可靠的研究材料以及方便快捷的服务，对购买项目的前期资料提供,中期合同保证,后期货物跟踪到*终售后的确保项目准确到位，都有相关专业人士进行维护,确保您在合肥合肥星肽生物科技有限公司公司获得*上等服务！
|
|
联系方式
|
何经理，合肥星肽生物科技有限公司，Tel：0551-63802898 400-8702-898，
E-mail：info@qingbio.com http://m.haomenmc.com QQ:514713116
|
1.) Ghada AK and J Golbahar. (2013) ?High Glucose-Induced Oxidative Stress Increases the Copy Number of Mitochondrial DNA in Human Mesangial Cells.? BioMed Research International. 2013: 1155-63
2.) Kang MK, Lim SS, Lee JY, Yeo KM, Kang YH. (2013) "Anthocyanin-Rich Purple Corn Extract Inhibit Diabetes-Associated Glomerular Angiogenesis." PloS one. 8: e79823.
3.) Li J, Lim SS, Lee ES, Gong JH, Shin D, Kang IJ, Kang YH. (2011) "Isoangustone A suppresses mesangial fibrosis and inflammation in human renal mesangial cells."Exp Biol Med (Maywood). 236: 435-44.
4.) Wu F, Zhang W, Li L, Zheng F, Shao X, Zhou J, Li H. (2011) "Inhibitory effects of honokiol on lipopolysaccharide-induced cellular responses and signaling events in human renal mesangial cells." Eur J Pharmacol. 654: 117-21.
5.) Huang P, Zhang Y, Jiang T, Zeng W, Zhang N. (2010) "Role of aldose reductase in the high glucose induced expression of fibronectin in human mesangial cells." Mol Biol Rep. 37: 3017-21.
6.) Li J, Kang SW, Kim JL, Sung HY, Kwun IS, Kang YH. (2010) "Isoliquiritigenin entails blockade of TGF-beta1-SMAD signaling for retarding high glucose-induced mesangial matrix accumulation." J Agric Food Chem. 58: 3205-12.
7.) Jiang T, Qu JJ, Nishinaka T, Zhang N. (2008) "Transcription factor AP-1 regulates TGF-beta(1)-induced expression of aldose reductase in cultured human mesangial cells." Nephrology (Carlton). 13: 212-7.
8.) Mathew JT, Patni H, Chaudhary AN, Liang W, Gupta A, Chander PN, Ding G, Singhal PC. (2008) "Aldosterone induces mesangial cell apoptosis both in vivo and in vitro."Am J Physiol Renal Physiol. 295: F73-81.
9.) Drel VR, Pacher P, Stevens MJ, Obrosova IG. (2006) "Aldose reductase inhibition counteracts nitrosative stress and poly(ADP-ribose) polymerase activation in diabetic rat kidney and high-glucose-exposed human mesangial cells." Free Radic Biol Med. 40: 1454-65.
10.) Li Y, Wen X, Spataro BC, Hu K, Dai C, Liu Y. (2006) "Hepatocyte growth factor is a downstream effector that mediates the antifibrotic action of peroxisome proliferator-activated receptor-gamma agonists." J Am Soc Nephrol. 17: 54-65.
11.) Wen X, Li Y, Hu K, Dai C, Liu Y. (2005) "Hepatocyte growth factor receptor signaling mediates the anti-fibrotic action of 9-cis-retinoic acid in glomerular mesangial cells."Am J Pathol. 167: 947-57.
12.) Dai C, Liu Y. (2004) "Hepatocyte growth factor antagonizes the profibrotic action of TGF-beta1 in mesangial cells by stabilizing Smad transcriptional corepressor TGIF." J Am Soc Nephrol. 15: 1402-12.
